Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06791356 · ClinicalTrials.gov registry record · NA

CBT-I in Older African American Adults

A NA study of Older Adults (65 Years and Older), sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06791356 is a NA study of Older Adults (65 Years and Older) that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 20 participants, below the 44-participant average among 4 other Older Adults (65 Years and Older) trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06791356, a NA study of Older Adults (65 Years and Older), is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Sleep problems, like insomnia, are common in older African Americans. About 25% of older adults in the US have at least 2 symptoms of insomnia, such as having trouble falling asleep, staying asleep, or getting good sleep for a month or more. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a recommended non-pharmacological treatment for insomnia. Unlike medicines that might only help for a short time or have many side effects, CBT-I deals with the root causes of insomnia. It helps people change how they think and act about sleep, leading to better habits and attitudes. This can make sleep better for a long time, even after the treatment is over. While CBT-I is commonly used among adults with insomnia, its benefits among older adults and specifically older African American adults are not well understood. Thus, the current pilot study will investigate the feasibility of CBT-I in older African American adults and establish preliminary evidence for the potential benefit of CBT-I on sleep as well as cognition in this population. For this study, participants will be asked to complete pencil-and-paper questionnaires, psychological tests of cognition, 7-day actigraphy, 2 nights of at home sleep monitoring, which collects specific sleep measures such as brain waves and sleep stage timing, and computer-based neuropsychological tests before and after intervention. Study interventions will consist of 8 weekly sleep training sessions via Zoom or a single session of education on strategies to improve sleep quality. Sleep training sessions will include education about strategies to improve sleep quality, changing thought process that contribute to insomnia, training the brain on the optimal sleep environment, and reducing sleep initially to establish a consistent sleep schedule before increasing sleep time. Three months after the post-intervention visit, participants will be asked to come back in for a follow-up evaluation which consists of complete pencil-and-paper questionn

Interventions

  • BEHAVIORAL Sleep hygiene education
  • BEHAVIORAL Cognitive-behavioral therapy for insomnia

Study Locations (1)

New Jersey

  • Rutgers University - Newark

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-06-02
Est. Completion 2027-06
Phase NA

What the Registry Record Tells You About NCT06791356

The ClinicalTrials.gov registry entry for NCT06791356 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 44-participant average among 4 other Older Adults (65 Years and Older) trials with a reported enrollment target (55% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Older Adults (65 Years and Older) appearing as the primary indexed condition, and to 2 interventions - of which Sleep hygiene education is the first listed.

NCT06791356 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06791356 about?

NCT06791356 is a clinical study titled "CBT-I in Older African American Adults". Sleep problems, like insomnia, are common in older African Americans. About 25% of older adults in the US have at least 2 symptoms of insomnia, such as having trouble falling asleep, staying asleep, or getting good sleep for a month or more. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a rec...

What is the current status of trial NCT06791356?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-02. Estimated completion is 2027-06.

What conditions does trial NCT06791356 study?

This clinical trial studies the following conditions: Older Adults (65 Years and Older).

What interventions are being tested in trial NCT06791356?

The interventions under investigation include: Sleep hygiene education (BEHAVIORAL), Cognitive-behavioral therapy for insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT06791356?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06791356 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Older Adults (65 Years and Older)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.